Forest oxycodone/ibuprofen
Executive Summary
Proposed brand name for Forest's oxycodone/ibuprofen fixed-dosed combination is Combunox. Forest will submit an additional clinical study in March to meet the recommendations set by FDA in a 2002 "approvable" letter (1"The Pink Sheet" Oct. 18, 2002, In Brief)...
You may also be interested in...
Forest pain combo “approvable”
Forest Labs' oxycodone/ibuprofen combination must undergo additional safety and efficacy testing, FDA says in deeming the pain product "approvable." Forest had expected approval by year-end (1"The Pink Sheet" Oct. 21, p. 23)...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.